Table 2.
Group | n | PGRN (pg/l) | IL-6 (pg/ml) | PR3 (ng/ml) | TNFR (ng/l) | TNFα (ng/l) | Anti-dsDNA antibodies (mg/l) |
---|---|---|---|---|---|---|---|
Pre-treatment |
30 |
17.82 ± 5.18#& |
1.56 ± 1.18#& |
49.33 ± 18.85# |
17.50 ± 10.33#& |
89.59 ± 20.27#& |
208.19 ± 194.24#& |
Post-treatment |
30 |
13.64 ± 4.51* |
0.97 ± 0.37* |
48.25 ± 10.89* |
10.61 ± 3.70* |
54.31 ± 17.17* |
137.02 ± 80.71* |
Control | 30 | 11.09 ± 1.62 | 0.70 ± 0.05 | 38.32 ± 3.55 | 9.76 ± 1.06 | 37.46 ± 11.63 | 23.24 ± 20.23 |
Note: #, p < 0.05, compared with the normal controls.
&, p < 0.05, compared with the post-treatment group.
*, p < 0.05, compared with the normal controls.